O
Organogenesis Holdings Inc. (ORGO)
NCM – Real Time Price. Currency in USD
2.41
+0.08 (3.43%)
At close: May 12, 2026, 4:00 PM EDT
2.41
0.00 (0.00%)
After-hours: May 12, 2026, 7:53 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.41
+0.08 (3.43%)
At close: May 12, 2026, 4:00 PM EDT
2.41
0.00 (0.00%)
After-hours: May 12, 2026, 7:53 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.53 | 2.52 | 10 | |
| Quick ratio | 3.16 | 1.78 | 10 | |
| Debt to Equity | 0.19 | -0.80 | 9.0 | |
| Debt to Assets | 0.14 | 0.73 | 8.0 | |
| Interest coverage | N/A | -13.90 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 451M | 433M | 482M | 564M | 515M |
| Gross Profit | 337M | 310M | 349M | 400M | 342M |
| Operating Income | 29M | 16M | 22M | 56M | 12M |
| Net Income | 16M | 5M | 861K | 37M | 3M |
| EBITDA | 47M | 40M | 47M | 83M | 45M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -46.44 | -376.52 | 1.0 |
| Next quarter | -45.91 | -197.79 | 1.0 |
| Current year | -49.97 | -355.68 | 1.0 |
| Next year | 22.01 | 68.92 | 10 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -83.49 | -221.63 | -218.33 | -48.27 | 1.0 |
| Y/Y | -57.05 | -182.09 | -115.49 | 176.32 | 3.3 |
| 3y average | 8.13 | 1350.11 | 944.35 | -183.15 | 6.8 |
| 5y average | 11.81 | 882.69 | 621.04 | -65.39 | 7.0 |
| Weighted average score | 4.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $92.1M significantly exceed its total debt $70.9M, ensuring strong financial flexibility
Total current assets $268.5M exceed Total current liabilities $76.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (-0.8), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
The company generates positive free cash flow $18.0M, supporting its financial health